JP Morgan Maintains Overweight on RH, Lowers Price Target to $190

Benzinga Newsdesk www.benzinga.com Negative 86.4%

Neg 86.4% Neu 0% Pos 0%

JP Morgan analyst Christopher Horvers maintains RH (NYSE:RH) with a Overweight and lowers the price target from $212 to $190.